No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
Alfresa Holdings Corporation, a Japanese company established in Tokyo in 2003, operates globally through its subsidiaries, specializing in the production, wholesale distribution, marketing, and international trade of pharmaceuticals, diagnostic reagents, and medical equipment. A significant part of its operations involves the wholesale supply of ethical pharmaceuticals, diagnostic reagents, and medical devices to healthcare providers including hospitals, clinics, and dispensing pharmacies. The company also manages the wholesale distribution of self-medication products, such as over-the-counter drugs, nutritional supplements, and health foods, to drugstores and pharmacies. Furthermore, Alfresa is engaged in the manufacturing and commercialization of active pharmaceutical ingredients, various pharmaceuticals, diagnostic reagents, and medical devices, alongside providing contract manufacturing services for pharmaceutical goods. Its medical-related division also encompasses the management of dispensing pharmacies and other associated healthcare activities.
www.alfresa.comNo one on the platform currently holds 2784.T.
No tracked institution reports a position in 2784.T as of their last filing.
No one on the platform has traded 2784.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 6.9% | 7.2% | 8.8% | — | — | — |
| Rev. Growth % | 4.8% | 3.5% | ||||
| Profit Margin % | 1.3% | 1.1% | 1.2% | |||
| Free Cash Flow Margin % | 0.5% | 0.6% | 0.6% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $3.20T | +3.1% | $131.08 | $120.90–$141.27 | — | 2 |
| 2028 | $3.27T | +2.3% | $141.49 | $124.03–$171.05 | — | 3 |
| 2029 | $3.34T | +2.1% | $150.56 | $149.40–$151.73 | — | 2 |
| 2030 | $3.42T | +2.4% | $159.14 | $157.75–$160.25 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | $32.96 | $13.85 | -58.0% |
| 2026-05-15 | $34.67 | $53.73 | +55.0% |
| 2026-02-10 | $65.45 | $112.56 | +72.0% |
| 2025-11-06 | $47.78 | $35.82 | -25.0% |
| 2025-08-06 | $37.10 | $27.53 | -25.8% |
| 2025-05-15 | $29.27 | $9.68 | -66.9% |
| 2025-02-10 | $48.18 | $62.60 | +29.9% |
| 2024-11-07 | $38.15 |
| $51.55 |
| +35.1% |
| -0.06% |
| $560.4B |
| — |
| 6849.TNihon Kohden Corporation | $1560.50 | +0.16% | $249.6B | — |
| 7459.TMediPal Holdings Corporation | $2923.50 | -0.51% | $598.4B | — |
Source: Financial Modeling Prep · peers by sector/industry